NBIX · US market
NEUROCRINE BIOSCIENCES
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$14.30bnFinancials dated 30 June 2026Price dated 1 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- US$705.50m
- Latest-quarter run-rate earnings
- US$577.60m
- Latest fiscal-year earnings
- US$478.60m
- Trailing revenue
- US$3.37bn
- Latest-quarter run-rate revenue
- US$3.84bn
- Latest fiscal-year revenue
- US$2.86bn
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- QCGAX · Quantified Common Ground Fund Advisor Class Shares3.82% weight · Holdings dated 30 June 2026
- FBT · First Trust NYSE Arca Biotechnology Index Fund3.53% weight · Holdings dated 30 June 2026
- IBRN · iShares Neuroscience and Healthcare ETF3.45% weight · Holdings dated 21 August 2026
- IBBQ · Invesco Nasdaq Biotechnology ETF2.86% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- PBE · Invesco Biotechnology & Genome ETF2.86% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- PXSAX · Impax Small Cap Fund Class A2.84% weight · Holdings dated 30 June 2026
- FTSAX · FullerThaler Behavioral Small-Mid Core Equity Fund A Shares2.52% weight · Holdings dated 30 June 2026
- FTGS · First Trust Growth Strength ETF2.51% weight · Holdings dated 30 June 2026
- MCOW · Pacer S&P MidCap 400 Quality FCF Aristocrats ETF2.17% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- BBH · VanEck Biotech ETF2.08% weight · Holdings dated 30 June 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 30 June 2026. Informational research, not investment advice.